Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains
about
sameAs
Advances in understanding monoclonal gammopathy of undetermined significance as a precursor of multiple myelomaAppraisal of immunoglobulin free light chain as a marker of responseImmunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myelomaMonoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective studyPrognostic value of the serum free light chain ratio in newly diagnosed myeloma: proposed incorporation into the international staging systemSerum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significanceImmunoglobulin free light chains and solitary plasmacytoma of boneSmoldering multiple myeloma.Efficient generation of monoclonal antibodies from single rhesus macaque antibody secreting cells.Immunoglobulin and free light chain abnormalities in Gaucher disease type I: data from an adult cohort of 63 patients and review of the literature.Assessment of free light chains in the cerebrospinal fluid of patients with lymphomatous meningitis - a pilot studySerum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure.Proteomics analysis of the peritoneal dialysate effluent reveals the presence of calcium-regulation proteins and acute inflammatory response.Association between abnormal serum free light chains ratio and known prognostic factors in lymphoma; a nephrology viewpoint.Association between the delta estimated glomerular filtration rate and the prevalence of monoclonal gammopathy of undetermined significance in Korean males.Circulating serum free light chains as predictive markers of AIDS-related lymphoma.Serum immunoglobulin free light chain measurements and heavy chain isotype usage provide insight into disease biology in patients with POEMS syndrome.Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort studyResidual serum monoclonal protein predicts progression-free survival in patients with previously untreated multiple myelomaIncreased serum free light chains precede the presentation of immunoglobulin light chain amyloidosis.Diagnostic accuracy of monoclonal antibody based serum immunoglobulin free light chain immunoassays in myeloma cast nephropathySerum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical features.Clinical course of light-chain smouldering multiple myeloma (idiopathic Bence Jones proteinuria): a retrospective cohort study.Elevated serum free light chains are associated with event-free and overall survival in two independent cohorts of patients with diffuse large B-cell lymphoma.Quantification of peptides from immunoglobulin constant and variable regions by LC-MRM MS for assessment of multiple myeloma patientsRapid detection of structural variation in a human genome using nanochannel-based genome mapping technology.Kappa free light chains: diagnostic and prognostic relevance in MS and CIS.Elevated monoclonal and polyclonal serum immunoglobulin free light chain as prognostic factors in B- and T-cell non-Hodgkin lymphomaElevation of serum immunoglobulin free light chains during the preclinical period of rheumatoid arthritis.Monoclonal and polyclonal serum free light chains and clinical outcome in chronic lymphocytic leukemia.Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndrome.Serum free light chains and the risk of ESRD and death in CKDThe Association between Polyclonal Combined Serum Free Light Chain Concentration and Mortality in Individuals with Early Chronic Kidney Disease.Serum protein electrophoresis under effective control of HIV-1 disease progression.Elevated Concentrations of Serum Immunoglobulin Free Light Chains in Systemic Lupus Erythematosus Patients in Relation to Disease Activity, Inflammatory Status, B Cell Activity and Epstein-Barr Virus Antibodies.Scleromyxedema: role of high-dose melphalan with autologous stem cell transplantation.Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantationThe pathogenesis and diagnosis of acute kidney injury in multiple myeloma.Assessment of Intrathecal Free Light Chain Synthesis: Comparison of Different Quantitative Methods with the Detection of Oligoclonal Free Light Chains by Isoelectric Focusing and Affinity-Mediated Immunoblotting.Free light chains and the risk of AIDS-defining opportunistic infections in HIV-infected individuals.
P2860
Q24619589-B6550D13-1C29-4D9C-B352-4C7ACD6786A9Q24624398-440FFFAB-E125-46F4-8B6F-A7FA5949555CQ24650785-B8C226DA-695A-4C85-BDC8-6B7D80FC8737Q24653006-63A21222-1BFD-4BCE-A3C5-EC85A26E89E4Q24653434-3905DD7C-814C-41BA-9E93-9FE752369CADQ24669898-F1B3373A-D3E5-4DC1-B7A4-E8096A8238CEQ24685868-A5AAC58B-EFB2-4976-88A9-2B0F1CDD81C3Q28082855-0DAE1149-4F5F-462A-A14E-C8DF60629F63Q30391848-73E7A501-0AC8-41F3-9B4A-8C7A84AEFA35Q31146661-9B8C9C02-2B2B-438D-9466-20B1F26A5717Q33301492-17211237-396D-41B6-A1BE-738162F6ED4BQ33371085-11157878-F2AE-4F35-B4B9-8AEAF817718DQ33616578-5568C0DB-38B4-4484-BDB3-8CE9BD188BB1Q33652326-021FE6CE-B517-4AEB-AFC2-DA6E01BCA8EDQ33667174-DA29A29D-00AB-4D33-A58B-C4845A5F75A7Q33710567-52A35CBF-7F4E-4C65-B180-A21C48BFD0F1Q33988217-FEA3E6CD-7919-429C-AB9E-82F81AF35229Q33997173-A664EC2D-3717-417F-830A-9D9C1985B67DQ34001363-464A73A3-7026-4570-87E8-9C8D5E373129Q34091229-D2B6D619-6E90-4A44-8702-F31107ED7DCDQ34370957-7A98AF54-C898-4F28-AA5B-E6A486F8EB39Q34450428-7453A94B-A8C4-4CE9-934C-E1F1ECA79939Q34455098-DA53D3D9-C71D-4491-910D-4B5E595C2EF3Q34866311-C5A6A9C5-6524-4DB7-8A5A-626691646C7AQ34997502-FE03A412-E86C-496E-8B7B-0B4670D9BB94Q35066595-4517FD43-D71D-4BFC-B80A-25251CED698BQ35126500-D6E1937E-6776-4276-9E08-299629264C7EQ35185207-98F39BED-7492-43E2-8030-4D246798ECB3Q35210847-1AD6A9BC-AF6E-4C05-8159-6591B6B4F358Q35212377-D6CE0596-BE8E-43E2-9716-E7917D4D85F6Q35638270-0EE6B0E4-4B1F-438C-BD72-0D7499986F51Q35664565-A234DC4D-6BF1-49AC-89D9-3B59F9B4EA30Q35680192-416EEEB7-76A5-4216-A6FA-E9C02A66FBD8Q35728932-2CE52F43-FF3A-4C60-BD39-B569FD2945E4Q35786726-1A1B83E3-7B88-4B7F-8875-68699CBD53ABQ35849268-FE3F4048-C6C3-4C6D-B1C5-C61BA26F7DB5Q35849610-5EEC1BAA-E7B0-4993-BBDB-B58F27F8E355Q36033448-B6477BBA-6C06-499F-8592-409D5D43904BQ36192934-60A65AE4-7DD1-420B-96BA-7C0F0082F6B7Q36338377-B67DF483-937D-479D-9845-B6BEA85649EC
P2860
Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Serum reference intervals and ...... ion of monoclonal light chains
@ast
Serum reference intervals and ...... ion of monoclonal light chains
@en
Serum reference intervals and ...... ion of monoclonal light chains
@nl
type
label
Serum reference intervals and ...... ion of monoclonal light chains
@ast
Serum reference intervals and ...... ion of monoclonal light chains
@en
Serum reference intervals and ...... ion of monoclonal light chains
@nl
prefLabel
Serum reference intervals and ...... ion of monoclonal light chains
@ast
Serum reference intervals and ...... ion of monoclonal light chains
@en
Serum reference intervals and ...... ion of monoclonal light chains
@nl
P2093
P3181
P1433
P1476
Serum reference intervals and ...... ion of monoclonal light chains
@en
P2093
James F Lymp
Jerry A Katzmann
Raynell J Clark
Robert A Kyle
Roshini S Abraham
Sandra Bryant
P304
P3181
P407
P577
2002-09-01T00:00:00Z